期刊文献+

膀胱癌细胞中锌指蛋白A20对核转录因子κB抑制的机制探讨 被引量:1

Possible mechanism of zinc finger protein A20 on nuclear transcription factor kappaB inhibition in urinary bladder cancer cell
下载PDF
导出
摘要 目的 为了探讨锌指蛋白A2 0在膀胱癌细胞中抑制核转录因子κB(NuclearTranscriptionFactorKappaB ,NF κB)作用的可能机制。方法 转染绿色荧光蛋白融合的A2 0质粒 (GreenFluorescentProteinfusedA2 0 ,GFP A2 0 )和A2 0显性失活突变体质粒 [GFP A2 0 (1- 36 8) ]入膀胱癌细胞T2 4 ,荧光显微镜观察质粒在细胞中表达情况 ,RT PCR检测肿瘤坏死因子受体I(Tu morNecrosisFactorReceptorⅠ ,TNFRⅠ )、核转录因子κB受体激活子配体 (ReceptorActivatorofNF κBLigand ,RANKL)、NF κB抑制蛋白ⅠκBα的mRNA表达变化。结果 转染 2 4h后 ,质粒在细胞中稳定表达 ,4 8h后表达继续增加。转染A2 0质粒或A2 0显性失活突变体质粒 2 4h及 4 8h后 ,TNFRⅠ和RANKLmRNA表达无明显变化 (P >0 .0 5 )。而在这两个时间点处 ,A2 0质粒转染可明显抑制细胞内ⅠκBαmRNA的表达 ;A2 0质粒处理组与未处理组之间、A2 0质粒转染组与显性失活突变体质粒转染组之间差异均有显著性 (P <0 .0 1)。结论 A2 0作用于TNFR的下游对NF κB起抑制作用 ,ⅠκBαmRNA可能作为NF κB报告基因受A2 0抑制。 Objective To explore the possible reason of NF-κB inhibition by A20 in urinary bladder cancer cell. Methods Green fluorescent protein fused A20(GFP-A20) plasmid and dominant-negative A20 [GFP-A20(1-368)] plasmid were transfected into bladder cancer cell line T24, their expressions in cancer cells were detected by fluorescence microscopy 24 hours and 48 hours later. Semi-quantitative RT-PCR was performed to study the change of TNFR-Ⅰ, RANKL, ⅠκBα mRNA levels. Results GFP-A20 and GFP-A20(1-368) plasmids were stably expressed in T24 cells 24 hours after transfection and increased furtherly at 48h. TNFR-I and RNAKL mRNA levels were not changed by A20(GFP-A20) and GFP-A20(1-368) plasmids 24h or 48h after transfection ( P >0.05). ⅠκBα was significantly inhibited in two time points after GFP-A20 transfection. However, ⅠκBα was not affected by GFP-A20(1-368) plasmid. The statistical analyses between GFP A20 group and untreated group, GFP-A20 group and GFP-A20(1-368) group by semi-quantitative assay were significantly different( P <0.01). Conclusion A20 acted at downstream of TNFR to produce NF-κB inhibition. ⅠκBα mRNA, a reporter gene of NF-κB, was inhibited by A20.
出处 《肿瘤》 CAS CSCD 北大核心 2003年第4期302-305,共4页 Tumor
关键词 膀胱癌 锌指蛋白A20 核转录因子ΚB 肿瘤坏死因子受体I 核转录因子出受体激活子配体 Bladder cancer Zinc finger protein A20 Nuclear transcription factor kappaB Tumor necrosis factor receptor Receptor activator of NF-κB ligand
  • 相关文献

参考文献9

  • 1Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF - induced NF - kappa B and cell death responses in A20 - deficientmice[J]. Science, 2000, 289(5488): 2350.
  • 2Zetoune FS, Murthy AR, Shao Z, et al. A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome[J]. Ctyokine, 2001, 15(6): 282.
  • 3Ferran C, Stroka DM, tMdrichani AZ, et al. A20 inhibits NFkappa B activation in endothelial cells without sensitizing to tumor necrosis factor - mediated aopotosis[J]. Blood, 1998, 91(7) : 2249.
  • 4Heyninck K, De Valek D, Vanden Berghe W, et al. The zinc finger protein A20 inhibits TNF- induced NF - kappa B dependent gene expression by interfering with an RIP or TRAF2 -mediated transaetivation signal and direetly binds to a novel NF- kappa B- inhibiting protein ABIN[J]. J Cell Biol, 1999; 145(7) : 1471.
  • 5Evans PC, Taylor ER, Coadwell J, et al. Isolation and characterization of two novel A20 - like proteins [ J ]. Biochem J,2001, 357(Pt 3).. 617.
  • 6Klinkenberg M, Van Huifel S, Heyninck K, et al. Functional redundancy of the zinc fingers of A20 for inhibition of NF - kappa B activation and protein - protein interactions [ J ]. FEES Lett, 2001, 498(1): 93.
  • 7Jaattela M, Mouritzen H, Elling F, et al. A20 zinc finger protein inhibits TNF and IL - 1 signaling[J]. J Immunol, 1996,156(3): 1166.
  • 8Ikeda T, Kasai M, Utsuyama M, et al. Determination of three isoforms of the receptor activator of nuclear factor - kappa B ligand and their differential expression in bone and thymus[J]. Endocrinology, 2001, 142(4): 1419.
  • 9Cooper JT, Stroka DM, Brost JAN. A20 hlocka endothdlal cell activation through a NF- kappa B - dependent mechanism[J]. J Biol Chem, 1996, 271(30): 18068.

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部